Cancer Research UK, SV Health Investors team up for speedy drug development
Cancer Research UK will collaborate closely with SV to identify promising, novel research from within the charity’s network that could be rapidly developed.
Read More
Tag: SV Health Investors
- FDA approves new high dose Spinraza regimen for SMA
- Viridian reports positive results from elegrobart phase 3 trial
- Cure Parkinson’s convenes expert panel to assess £2 million combination therapy funding call
- Kygevvi approved in Europe as first treatment for TK2d
- Tozorakimab shows significant benefit in two major COPD trials
